Background: Cerebrospinal fluid (CSF) analysis aids in categorizing underlying disease processes in patients with neurologic disease. Convention suggests that CSF should be collected caudal to the lesion. However, little evidence exists to justify this assertion.
| INTRODUCTION
Cerebrospinal fluid (CSF) collection and analysis are routinely performed to categorize the type of central nervous system (CNS) disease present in patients with neurologic disease. In dogs, CSF is collected from either the cerebellomedullary (CM) or the lumbar cisterns. Because of the caudal flow of CSF, it is common practice to collect CSF caudal to and in close proximity to the lesion. 1 However, some investigators suggest that the CM cistern is more reliable regardless of the lesion location, 2, 3 whereas others suggest collection from the lumbar cistern is more likely to disclose abnormal results. 4, 6, 7 In clinical practice, the choice of CSF collection location also is influenced by other factors including clinician preference and experience, patient anatomy, and patient safety.
To our knowledge, no large studies have compared paired CM and lumbar CSF samples in the same patient with neurologic disease.
One previous study compared lumbar and CM CSF samples in 31 healthy dogs and found that total protein (TP) concentration was higher in lumbar samples whereas white blood cell count was higher in CM samples. 5 Another frequently cited study compared CSF analysis between CM and lumbar collection in dogs with neurologic disease, but only 13 dogs had paired samples, and the remainder were compared between different patients. 7 Therefore, correlations between CM and lumbar samples could not be made because these patients likely had different underlying diseases, different disease severity, and different lesion localizations.
To provide the best treatment recommendations and accurately establish a prognosis for patients, selecting the collection site most likely to yield a diagnosis is critical. Our objective was to evaluate differences between paired CM and lumbar CSF samples obtained in dogs with neurologic disease. We aimed to provide guidance as to which site is more likely to aid in diagnosis and the likelihood of false negative results based on lesion localization. We hypothesized that differences in the total nucleated cell count (TNCC) and TP concentration would exist between CM and lumbar samples collected from the same patient. Our second hypothesis was that the most representative collection would be obtained caudal to the lesion and that increasing distance from the lesion would result in decreased TP concentration and TNCC.
| MATERIALS AND METHODS
Fifty dogs were prospectively recruited from patients presented to the University of Illinois Veterinary Teaching Hospital for neurodiagnostic evaluation in which CSF analysis was clinically recommended.
The study was approved by and conducted in accordance with the University of Illinois Institutional Animal Care and Use Committee. To be enrolled in the study, dogs were required to have magnetic resonance imaging (MRI) before CSF collection. The initial CSF collection site was chosen by the supervising clinician. If a sample could not be obtained from 1 of the locations after 3 attempts, the patient was not enrolled in the study.
Samples were collected into sterile glass tubes with no additives and into EDTA tubes. Analysis was performed on the EDTA sample within 30 minutes of collection, including TNCC, red blood cell (RBC) count, TP concentration, and preparation of a cytocentrifuge slide.
Total nucleated cell and RBC counts were performed manually, using the mean of counts from both sides of the hemocytometer chamber. 
| RESULTS
Sixty-two dogs qualified for enrollment in the study and informed client consent was obtained before sample collection. Cerebrospinal fluid could not be collected from 11 dogs. Collection of CSF was unsuccessful from the lumbar cistern in all 11 patients, and unsuccessful from both sites in a single patient. Fifty-one paired samples were collected. Enrolled patients were subdivided into 1 of 4 neurolocalizations: intracranial, cervical, thoracolumbar, and multifocal. The sample population consisted of 23 dogs with intracranial localization, 13 dogs with cervical myelopathy, 13 with thoracolumbar myelopathy, and 2 with multifocal neurolocalization. The most common presumptive diagnosis was meningoencephalitis or myelitis of unknown origin (MUO; n = 13), intervertebral disc disease (IVDD; n = 9), idiopathic epilepsy (n = 5), neoplasia (n = 4), cognitive dysfunction (n = 2), and discospondylitis (n = 2). All presumptive or confirmed diagnoses along with CSF results are included in Supplemental Table 1 . In samples from the CM cistern, the median TNCC was 2 (0-1955) cells/mm 3 , the median RBC count 27 (0-55 044) cells/mm 3 , and the median TP concentration 31.3 (14.1-709.8) mg/dL. In the CSF collected from the lumbar cisterna, the median TNCC was 9 (0-2772) cells/mm 3 , the median RBC count was 1052 (7-271 000) cells/mm 3 , and the median TP concentration was 100.6 (28.7-3724) mg/dL (Figures 1 and 2) .
Overall, differences among the TNCC (P < .001), RBC count (P < .001), and TP concentration (P < .001) between the CM and lumbar cisterns were significant (Table 1) . Data then were grouped and analyzed by neurolocalization (intracranial, cervical, or thoracolumbar). The TP concentration (intracranial, P ≤ .001; cervical, P < .001; thoracolumbar, P < .001) and RBC count (intracranial, P < .001; cervical, P = .002; thoracolumbar, P = .006) were significantly different among the 3 neurolocalizations. The TNCC was significantly different in the thoracolumbar (P = .004), and cervical (P = .04) cases, but not for intracranial (P = .30) localizations (Table 1) . Hemodilution (RBC > 500 cells/mm 3 ) was present in samples taken from the CM cistern in 3 cases, from the lumbar cistern in 22 cases, and from both sites in 5 cases. Hemodilution was more likely to occur in samples obtained from the lumbar cistern compared to the CM cistern (P < .001).
The pathologist interpretation, with regard to TNCC, TP con- 
| DISCUSSION
We found that CSF results differed significantly between the CM and lumbar cisterns in dogs with neurologic disease. To our knowledge, ours is the first study comparing paired CSF samples collected from both sites in a large number of dogs with neurologic disease. In dogs with thoracolumbar localization, CSF collected from the CM cistern was likely to cause a false negative result. Dogs with intracranial or cervical neurolocalization however had more inconsistent results, indicating CSF collection from both sites may be beneficial.
In this population of dogs, lesions in the thoracolumbar spinal cord were unlikely to cause abnormal results when samples were collected from the CM cistern. This finding is in agreement with a previous study evaluating creatine kinase and lactate dehydrogenase activities in paired CSF samples in dogs with thoracolumbar intervertebral disc disease, which found that these 2 enzyme activities were less likely to be abnormal in samples from the CM site. 6 Another study evaluating CSF in dogs with neurologic disease also concluded that CSF was more likely to be abnormal when collected from a site caudal to the lesion, but the majority of samples in this study were not paired. 7 Cerebrospinal fluid mainly is produced by the choroid plexus in the brain and travels caudally in the CNS. 3, 8, 9 It is absorbed back into the peripheral circulation through 1-directional valves in the arachnoid villi in the subarachnoid space. 8, 9 Thus, increased TP concentration or TNCC or both can be present because of injury anywhere along the CSF pathway as a result of changes in production of CSF, breakdown in protective barriers, or disrupted resorption. 4, 9 We suspect that, in these particular cases, obstruction or resorption of CSF may be the predominant cause of the abnormalities, resulting in different CSF findings in different parts of the CNS. Studies in normal dogs have reported higher TNCC in CSF collected from the CM compared to the lumbar cistern, 5 whereas other studies have reported higher TNCC from the lumbar cistern. 6 Possible explanations for this difference could be related to variability in the permeability of the subarachnoid space or rates of cell lysis throughout the CNS. 4 Cerebrospinal fluid analysis generally includes quantitative determination of TNCC, RBC count, and TP concentration, as well as interpretation of these results and cytology findings by a clinical pathologist.
This interpretation is a succinct summary of the clinicopathologic characteristics of the CSF. In our study, the pathologist's interpretation varied between collection sites in the majority of cases in patients with all Abbreviations: CM, cerebellomedullary; TNCC, total nucleated cell count.
3 neurolocalizations. The majority of this data is reflected in the quantitative analysis already discussed, indicating that TNCC and TP concentration often were different between collection sites. Evaluating the pathologist's interpretation also indicated that 5 cases had a shift in the cell population causing the pleocytosis. Two of these cases neurolocalized intracranially, 2 to the cervical spine, and 1 to the thoracolumbar spine. The presumptive diagnosis in these cases also varied, with 2 having focal lesions (IVDD, vertebral subluxation), RBC/μL did not affect CSF TNCC or TP concentration, respectively. 10, 11 Because of the lack of consensus, as well as lack of direct correlation between RBC count and other CSF variables, we elected to include all samples in our initial statistical analysis. The goal of this analysis was to detect the extent of difference between the 2 samples, thus the study included all samples acquired so as to be more reflective of a clinical setting. However, when analyzing samples for pleocytosis and increased TP concentration, those samples with RBC count >13 200 cell/mm 3 were excluded. This cutoff was based on a commonly cited report that indicated that the presence of up to 13 200 cells/mm 3 did not affect CSF TP concentration or TNCC in patients with neurologic disease. 10 For our data analysis, an objective quantitative cutoff was used to categorize these samples (ie, pleocytosis is defined as TNCC >5 cells/mm 3 ), and thus even a subtle increase in TNCC because of hemodilution would affect the results.
Another limitation of our study was that the entire CNS was not imaged in any patient. Some of the patients with abnormal results at only 1 CSF collection site could have had a lesion in a location that was not imaged, and thus missed. Performing MRI of the entire CNS in each patient is not routine in clinical practice, and is not practical from a patient health or financial perspective. In a clinical setting, the imaging location is chosen based on neurolocalization after a thorough neurological examination. Our study was designed to make recommendations about CSF collection site based on a clinical neurodiagnostic evaluation and to be more representative of clinical practice. As such, it is possible that additional lesions were missed, which could have affected CSF interpretation. Another potential limitation is that the first CSF collection site was chosen by the supervising clinician in each case. An alternative option would have been to randomly choose which site was collected first. However, a previous study evaluating paired CSF samples in healthy dogs determined that the order of collection did not affect the CSF results. 5 This previous study has not been repeated in patients with neurologic disease, and thus the order of collection may have affected our results.
Cerebrospinal fluid collection and analysis are important parts of the neurodiagnostic evaluation, often guiding treatment plans and prognosis. Ideally, the clinician should choose the collection site most likely to yield abnormal results. Based on our results, in patients with thoracolumbar myelopathy, collection of CSF caudal to the lesion was more consistently abnormal compared to CSF from the CM cistern. In these patients, CSF collected from the CM cistern was likely to be normal, providing a false negative result. In patients with intracranial localization or cervical myelopathy, neurolocalization did not predict which site was more likely to be abnormal. In these patients, it may beneficial to collect and analyze CSF from both the CM and lumbar cisterns.
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